Vestal Point Capital, LP
Q1 2025 13F Holdings
- Locationnew york, NY
- Num holdings
63
- Value ($000)
$1,400,317
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001974915
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ACLX Arcellx Inc | COMMON STOCK | 03940C100 | $156.63M | 11 % | 2,387,720 | ||
CYTK Cytokinetics Inc | COM NEW | 23282W605 | $104.11M | 7 % | 2,590,531 | ||
INSM Insmed Inc | COM PAR $.01 | 457669307 | $82.01M | 6 % | 1,075,000 | ||
NUVL Nuvalent Inc | COM | 670703107 | $76.24M | 5 % | 1,075,000 | ||
VERA Vera Therapeutics Inc | CL A | 92337R101 | $60.05M | 4 % | 2,500,000 | ||
KALV KalVista Pharmaceuticals Inc | COM | 483497103 | $54.83M | 4 % | 4,751,292 | ||
uniQure NV | SHS | N90064101 | $50.80M | 4 % | 4,792,572 | ||
CRNX Crinetics Pharmaceuticals Inc | COM | 22663K107 | $50.31M | 4 % | 1,500,000 | ||
Xenon Pharmaceuticals Inc | COM | 98420N105 | $43.62M | 3 % | 1,300,000 | ||
SRRK Scholar Rock Holding Corp | COM | 80706P103 | $41.80M | 3 % | 1,300,000 |
Rows Per Page
10
- 10
- 50
- 100